Searchable abstracts of presentations at key conferences in endocrinology

ea0077p190 | Metabolism, Obesity and Diabetes | SFEBES2021

Outcomes of Bariatric surgery in adolescents and youth in an Arab population: a single centre experience

Radha Saradalekshmi Koramannil , Ali Tomader , Baqer Amal , Lessan Nader

Background: Obesity is increasing in prevalence in younger people, including children and adolescents. Bariatric surgery (BS) is well-established and efficacious treatment for morbid obesity in adults. BS is being performed in younger age groups more frequently.Objective: To describe outcomes of BS under the age of 25 in Emirati individuals having follow-up at Imperial College London Diabetes Centre (ICLDC).Methods: Patients recrui...

ea0077p256 | Thyroid | SFEBES2021

Audit of Liothyronine Prescribing at the University Hospitals of Leicester (UHL) NHS Trust

Al Jumaah Ali , Levy Miles , Bhake Ragini , Reddy Narendra

Introduction: Levothyroxine is the first choice treatment for patients with hypothyroidism However, some people would continue to have symptoms of thyroid disease despite biochemical control on levothyroxine. Others might be intolerant to levothyroxine.Aim: The aim of this audit is to evaluate UHL endocrinology practice against local and national guidelines with regards to prescribing and monitoring of liothyronine treatment in 2019.<p class="abstext...

ea0055oc1 | National Clinical Cases | SFEEU2018

Testosterone secreting clear cell ovarian tumor in a patient with Von Hippel Lindau (VHL) disease

Rehman Tejhmal , Hameed Ali , Snape Katie , Hodgson Shirley , Bano Gul

The VHL gene is a tumor suppressor gene located on chromosome 3p25.3. Mutations in this gene prevent production of the VHL protein and as a result, cells grow and divide uncontrollably to form the tumors and cysts. Germline VHL gene mutations predispose to a variety of tumors, most commonly retinal and cerebellar haemangioblastomas, renal cell carcinoma and phaeochromocytoma. Papillary cystadenomas of the epidididymis are seen in 10–26% of men are rarely...

ea0055p11 | Poster Presentations | SFEEU2018

A challenging case of rapidly enlarging thyroid mass

Rehman Tejhmal , Hameed Ali , Kim Dae , Pettengell Ruth , Bano Gul

A 60 year old Caucasian woman presented with a three month history of rapidly enlarging neck swelling and hoarseness of voice. Her past medical history included Hypothyroidism. Her neck ultrasound scans showed 3.5 cm left thyroid nodule with bilateral lymphadenopathy (U5). The Fine needle aspiration (FNA) revealed densely grouped variable sized irregular epithelial cells with nuclear atypia and spindle shaped fragments with focal areas of lymphocytic thyroiditis. The different...

ea0055we7 | Workshop E: Disorders of the adrenal gland | SFEEU2018

A hypertensive emergency post massive phaeochromocytoma resection: catecholamines not to blame

O'Toole Sam , Rathore Ali , Brown Morris , Akker Scott

Case history: A 26 year-old lady was admitted from clinic with severe hypertension and bilateral papilloedema. Six weeks prior to admission she had undergone resection of a massive right upper quadrant lesion that was felt to be of hepatic origin. Histological analysis of the lesion revealed it to be an adrenal phaeochromocytoma and she was thus referred to the endocrine service. Pre-operative biochemical assessment had not been performed but there was no evidence of any blood...

ea0081p85 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Ramadan fasting without the doctor’s consent: which patient, and what impact? Results of a prospective study

Halouache Ali , Yassine Errahali , Sanae Chakdoufi , Jad Isouani , Anas Guerboub

Background and aims: The objective of our study is to evaluate the respect of Muslim diabetics for the contraindication of fasting and the control metabolic impact of fasting during the month of Ramadan. Materials and methods: This analytical cross-sectional study was conducted during the period from Mars to June of the year 2021, within the department of endocrinology and metabolic diseases of the Military Hospital of Instruction Moham...

ea0081p212 | Thyroid | ECE2022

Identifying the use of clinical and radiological parameters to assess moderate-severe Graves’ Orbitopathy − a multi-centre analysis of the characteristics of patients with Graves’ Orbitopathy

George Nicole , Lee Vickie , Feeney Claire , Bhatia Kunwar , Ali Amina

Background: Early diagnosis and surveillance of Graves’ Orbitopathy (GO) is essential to prevent severe, sight-threatening complications and long-term disability; therefore, it is highly desirable to identify risk factors and early predictors of severe disease. GO is clinically assessed using the Clinical Activity Score (CAS) and the EUGOGO Severity Scale (ESS), which are subjective, qualitative tests that are used to evaluate the activity and severity at the anterior orb...

ea0081ep53 | Adrenal and Cardiovascular Endocrinology | ECE2022

Syncope: an unusual presentation of a rare disease

Ali Uzair Akbar , Sadiq Muhammad Sajjad , Brosnan Elizabeth Ann

Background: Syncope is common in healthy adolescents and young adults. It can happen due to hypotension secondary to orthostasis. Primary adrenal insufficiency is infrequently reported in patients presenting with syncope and dizziness caused by loss of vasopressor effect of catecholamines and volume depletion.Clinical Case: A 17-year-old boy with a past medical history of learning disability and asthma presented to our health facility with an episode of ...

ea0081ep211 | Calcium and Bone | ECE2022

Acute confusional state as presenting feature in severe para-neoplastic hypercalcemia

Ali Uzair Akbar , Rana Ghazanfar Iqbal , Jannat Summan

Background: Hypercalcemia is a common clinical problem. Severe hypercalcemia or hypercalcemic crisis is an endocrine emergency and can be life threatening if left untreated. The condition has high mortality and requires immediate therapeutic interventions and diagnostics. A rapid rise to the calcium levels can result in the impaired function of organ systems including central nervous system. Hypercalcemia is mainly (more than 90%) caused by primary hyperparathyroidism or malig...

ea0081ep239 | Calcium and Bone | ECE2022

How we managed malignant hypercalcemia in a hyperparathyroid in heart failure in the emergency room

Halouache Ali , Yassine Errahali , Sanae Chakdoufi , Jad Isouani , Anas Guerboub

Introduction: We report a case of malignant hypercalcemia complicated by acute pancreatitis, in a patient whose cardiac insufficiency obliged us to use an unconventional therapeutic means: calcimimeticsCase Report: Mrs. Halima, 74 years old, had a history of arterial hypertension complicated by ischemic heart disease at the stage of heart failure. She consulted the emergency room for typical pancreatic pain, the biological workup found a lipasemia at 30 ...